Literature DB >> 9836383

Oral tolerance and the treatment of rheumatoid arthritis.

H L Weiner1, Y Komagata.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9836383     DOI： 10.1007/bf00832013

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  116 in total

1.  Oral tolerance in a murine model of relapsing experimental autoimmune uveoretinitis (EAU): induction of protective tolerance in primed animals.

Authors:  S R Thurau; C C Chan; R B Nussenblatt; R R Caspi
Journal:  Clin Exp Immunol       Date:  1997-08       Impact factor: 4.330

2.  FACS-sorted spleen and Peyer's patch dendritic cells induce different responses in Th0 clones.

Authors:  M P Everson; D G Lemak; J R McGhee; K W Beagley
Journal:  Adv Exp Med Biol       Date:  1997       Impact factor: 2.622

3.  Effect of oral beta interferon on subsequent immune responsiveness.

Authors:  P A Nelson; Y Akselband; S M Dearborn; A Al-Sabbagh; Z J Tian; P A Gonnella; S S Zamvil; Y Chen; H L Weiner
Journal:  Ann N Y Acad Sci       Date:  1996-02-13       Impact factor: 5.691

4.  The role of small intestinal antigen-presenting cells in the induction of T-cell reactivity to soluble protein antigens: association between aberrant presentation in the lamina propria and oral tolerance.

Authors:  H M Harper; L Cochrane; N A Williams
Journal:  Immunology       Date:  1996-11       Impact factor: 7.397

5.  Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation.

Authors:  W W Hancock; M H Sayegh; C A Kwok; H L Weiner; C B Carpenter
Journal:  Transplantation       Date:  1993-05       Impact factor: 4.939

6.  The regulation of immune responses to dietary protein antigens.

Authors:  A M Mowat
Journal:  Immunol Today       Date:  1987

7.  Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat.

Authors:  M H Sayegh; S J Khoury; W W Hancock; H L Weiner; C B Carpenter
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

8.  Inhibition of T-cell responses by feeding peptides containing major and cryptic epitopes: studies with the Der p I allergen.

Authors:  G F Hoyne; M G Callow; M C Kuo; W R Thomas
Journal:  Immunology       Date:  1994-10       Impact factor: 7.397

9.  Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye.

Authors:  G Wildner; S R Thurau
Journal:  Eur J Immunol       Date:  1995-05       Impact factor: 5.532

10.  Antigen-driven bystander suppression after oral administration of antigens.

Authors:  A Miller; O Lider; H L Weiner
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307
View more
  3 in total

Review 1.  Oral tolerance and gut-oriented immune response to dietary proteins.

Authors:  O Alpan
Journal:  Curr Allergy Asthma Rep       Date:  2001-11       Impact factor: 4.806

2.  Oral administration of Alequel, a mixture of autologous colon-extracted proteins for the treatment of Crohn's disease.

Authors:  Eran Israeli; Yaron Ilan
Journal:  Therap Adv Gastroenterol       Date:  2010-01       Impact factor: 4.409

3.  Oral mixture of autologous colon-extracted proteins for the Crohn's disease: A double-blind trial.

Authors:  Eran Israeli; Ehud Zigmond; Gadi Lalazar; Athalia Klein; Nilla Hemed; Eran Goldin; Yaron Ilan
Journal:  World J Gastroenterol       Date:  2015-05-14       Impact factor: 5.742
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.